The conserved target of rapamycin (TOR) proteins are involved in sensing nutrient levels and/or stress and the resultant control of cell growth, size, and survival. The authors assess mammalian TOR (mTOR) kinase expression in the mouse ovary and also the expression of its cofactors, Raptor, Rictor, and LST8. In granulosa cells, mTOR demonstrates high cytoplasmic/perinuclear expression. The kinase-active serine 2448—phosphorylated form of mTOR (P-mTOR) is present at very high levels during the M-phase. P-mTOR was enriched on or near the mitotic spindle and also near the contractile ring during cytokinesis. Rapamycin inhibition of mTOR resulted in both reduced granulosa cell proliferation and reduced follicle growth in vitro, each in a dose-dependent fashion. Follicles cultured in rapamycin did not undergo atresia. mTOR inhibition results in a reduction in granulosa cell proliferation, supporting a model in which stress and nutritional cues may directly influence ovarian follicle growth.
Quirk SM, Cowan RG, Harman RM, Hu CL, Porter DAOvarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci.2004 ; 82(E-suppl).
2.
Pangas SA, Matzuk MMGenetic models for transforming growth factor beta superfamily signaling in ovarian follicle development. Mol Cell Endocrinol. 2004;225:83-91.
3.
Wullschleger S., Loewith R., Hall MNTor signaling in growth and metabolism. Cell. 2006;124:471-484.
4.
Eskelinen EL , Prescott AR, Cooper J., et al. Inhibition of autophagy in mitotic animal cells. Traffic. 2002;3:878-893.
5.
Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RTMechanism of action of rapamycin: new insights into the regulation of g1-phase progression in eukaryotic cells. Prog Cell Cycle Res. 1995;1:53-71.
6.
Kim DH, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110:163-175.
7.
Kim DH, Sabatini DMRaptor and mTOR: subunits of a nutrient-sensitive complex. Curr Topics Microbiol Immunol. 2004;279:259-270.
8.
Jacinto E., Loewith R., Schmidt A., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol.2004 ;6:1122-1128.
9.
Wullschleger S., Loewith R., Oppliger W., Hall MNN.Molecular organization of target of rapamycin complex 2. J Biol Chem . 2005;280:30697-30704.
10.
Sarbassov DD , Ali SM, Sengupta S., et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and akt/pkb. Mol Cell. 2006 ;22:159-168.
11.
Heitman J., Movva NR, Hall MNTargets for cell cycle arrest by the immunosuppressant rapamycin in yeast . Science. 1991;253:905-909.
12.
Choe G., Horvath S., CloughesyTF, et al. Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res.2003;63:2742-2746.
13.
Zhou X., Tan M., Stone Hawthorne V., et al. Activation of the akt/mammalian target of rapamycin/4e-bp1 pathway by erbb2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res.2004;10:6779-6788.
14.
Altomare DA, Wang HQ, Skele KL, et al. Akt and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004;23:5853-5857.
15.
Chiang GG, Abraham RTPhosphorylation of mammalian target of rapamycin (mTOR) at ser-2448 is mediated by p70s6 kinase. J Biol Chem. 2005;280:25485-25490.
16.
Nav BT, Ouwens M., Withers DJ, Alessi DR, Shepherd PRMammalian target of rapamycin is a direct target for protein kinase b: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J.1999;344(pt 2):427-431.
17.
Sekuli A., Hudson CC, Homme JL, et al. A direct linkage between the phosphoinositide 3-kinase-akt signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res.2000;60:3504-3513.
18.
Alam H., Maizels ET, Park Y., et al. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/akt/ras homolog enriched in brain (rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem.2004;279:19431-19440.
19.
Arvisais EWW , Romanelli A., Hou X., Davis JSS.Aktindependent phosphorylation of TSC2 and activation of mTOR and ribosomal protein s6 kinase signaling by prostaglandin f2α. J Biol Chem. 2006;281:26904-26913.
20.
Zhang X., Shu L., Hosoi H., Murti GK, Houghton PJPredominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem. 2002;277:28127-28134.
21.
Drenan RM, Liu X., Bertram PG, Zheng XFFkbp12-rapamycin associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus . J Biol Chem. 2004; 279:772-778.
22.
Berven LA,Willard FS, Crouch MFRole of the p70s6k pathway in regulating the actin cytoskeleton and cell migration . Exp Cell Res. 2004;296:183-195.
23.
Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G.X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod. 2004;10:33—-41.
24.
Neale D., Demasio K., Illuzi J., Chaiworapongsa T., Romero R., Mor G.Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis . J Matern Fetal Neonatal Med. 2003;13:39-44.
25.
Cortvrindt R., Smitz J.,Van Steirteghem ACAssessment of the need for follicle stimulating hormone in early preantral mouse follicle culture in vitro. Hum Reprod. 1997;12:759-768.
26.
Tapia C., Kutzner H., Mentzel T., Savic S., Baumhoer D., Glatz K.Two mitosis-specific antibodies, 508 mpm-2 and phosphohistone h3 (ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol. 2006;30:83-89.
27.
Dormond O., Madsen JC, Briscoe DMThe effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J Biol Chem. 2007 ;282:23679-23686.
28.
Migita K., Eguchi K., Ichinose Y., et al. Effects of rapamycin on apoptosis of rheumatoid synovial cells . Clin Exp Immunol. 1997;108:199-203.
Hidayat S., Yoshino K., Tokunaga C., Hara K., Matsuo M., Yonezawa K.Inhibition of amino acid-mTOR signaling by a leucine derivative induces g1 arrest in Jurkat cells. Biochem Biophys Res Commun. 2003;301:417-423.
31.
Gao N., Flynn DC, Zhang Z., et al. G1 cell cycle progression and the expression of g1 cyclins are regulated by PI3K/AKT/ mTOR/P70S6K1 signaling in human ovarian cancer cells . Am J Physiol Cell Physiol. 2004;287:C281-C291.
32.
Song J., Salek-Ardakani S., So T., Croft M.The kinases aurora b and mTOR regulate the g1s cell cycle progression of T lymphocytes. Nat Immunol. 2006;8:64-73.
33.
van Opstal A., Boonstra J.Inhibitors of phosphatidylinositol 3-kinase activity prevent cell cycle progression and induce apoptosis at the M/G1 transition in CHO cells. Cell Mol Life Sci. 2006;63:220-228.
34.
Rubio-Viqueira B., Hidalgo M.Targeting mTOR for cancer treastment . Curr Opin Investig Drugs. 2006;7:501-512.
